Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Stroke is a severe clinical manifestation of sickle cell anemia (SCA). Despite the prognostic relevance of transcranial Doppler (TCD), more accurate tools to assess stroke risk in children with SCA are required. Here, we describe the effect of clinical, laboratory, and molecular features on the risk of stroke and high-risk TCD in children from the newborn cohort of Minas Gerais, Brazil. Outcomes studied were acute cerebral ischemia and high-risk TCD. Clinical and hematological data were retrieved from children's records. Genetic markers, which were known for their association with stroke risk, were genotyped by polymerase chain reaction/restriction fragment length polymorphism and sequencing. The cumulative incidence of acute cerebral ischemia by the age of 8 years was 7.4 % and that of high-risk TCD by the age of 11.5 years was 14.2 %. The final multivariate model for acute cerebral ischemia risk included high white blood cell count and reticulocyte count, acute chest syndrome rate, and the single nucleotide polymorphisms (SNPs) TEK rs489347 and TNF-α rs1800629. The model for high-risk TCD included high reticulocyte count and the SNPs TEK rs489347 and TGFBR3 rs284875. Children with risk factors should be considered for intensive risk monitoring and for intervention therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational studies have shown that reticulocytosis (149), low HbF levels, leukocytosis (150, 151), and complications such as ACS (81) are associated with an increased risk of stroke.”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [151]
Citations
Cites
Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
Kanda, Y. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2012.244 · Cited by 18,767
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
The Risk of Transfusion-Transmitted Viral Infections
Schreiber, G. B., Busch, M. P., Kleinman, S. H., & Korelitz, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342601 · Cited by 1,867
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Stuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 819
Discontinuing Prophylactic Transfusions Used to Prevent Stroke in Sickle Cell Disease
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa050460 · Cited by 635
Research works printed but not linked: 1
- Jesus JA, Araujo PIC (2012) Sickle cell disease: basic management for treatment. vol first edition. Ministry of Health, Brasília
Cited by
Pathophysiology of Sickle Cell Disease
Sundd, P., Gladwin, M. T., & Novelli, E. M. (2019) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012838 · Cited by 813
Determinants of severity in sickle cell disease
Rees, D. C., Brousse, V. A. M., & Brewin, J. N. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100983 · Cited by 110
Ataga, K. I., Gordeuk, V. R., Agodoa, I., Colby, J. A., Gittings, K., & Allen, I. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229959 · Cited by 59
“3 Risk of PHT Bakanay, 2005 [28] Retrospective US 226 16–68 Mortality Belisario, 2016 [29] Prospective cohort (2 cohorts) Brazil 395 At time of stroke or end of f/u: 4.”
BackgroundGenetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis
Kirkham, J. K., Estepp, J. H., Weiss, M. J., & Rashkin, S. R. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.37484 · Cited by 54
Measuring success: utility of biomarkers in sickle cell disease clinical trials and care
Kalpatthi, R. V., & Novelli, E. M. (2018) · Hematology · doi:10.1182/asheducation-2018.1.482 · Cited by 51
Genetic modifiers of severity in sickle cell disease
Chang, A. K., Summarell, C. C. G., Birdie, P. T., & Sheehan, V. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189004 · Cited by 32
“Bernaudin et al. showed an association of abnormal transcranial Doppler ultrasound (TCD) and stroke risk with co-inherited G6PD deficiency [53], though others have failed to show this association [54].”
InfluentialStroke and stroke prevention in sickle cell anemia in developed and selected developing countries
Bhattacharya, P., Sarmah, D., Dave, K. R., Goswami, A., Watanabe, M., Wang, X., Kalia, K., Plesnila, N., Yavagal, D. R., & Alvarez, O. A. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117510 · Cited by 28
Stroke in sickle cell disease and the promise of recent disease modifying agents
Runge, A. S., Brazel, D., & Pakbaz, Z. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120412 · Cited by 30
“sion of adhesion molecules (Lu/BCAM, ICAM-4, and LFA-3 specifically), and reticulocytosis has been established as a key predictor of stroke and abnormally elevated TCD results in infants [58,59].”
BackgroundBelisário, A. R., Silva, C. M., Velloso‐Rodrigues, C., & Viana, M. B. (2017) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.bjhh.2017.08.008 · Cited by 29
Self-citationRankine‐Mullings, A., Morrison‐Levy, N., Soares, D., Aldred, K., King, L., Ali, S. B., Knight‐Madden, J., Wisdom‐Phipps, M., Adams, R. J., Ware, R. E., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15162 · Cited by 26
Jung, J., Lu, Z., de Smith, A. J., & Mancuso, N. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad174 · Cited by 18
“Previous studies showed that high reticulocyte count or reticulocytosis are risk factors for stroke in children with sickle cell disease [41–43].”
ResultOjewunmi, O. O., Adeyemo, T. A., Oyetunji, A. I., Benn, Y., Ekpo, M. G., & Iwalokun, B. A. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23802 · Cited by 11
Sabarense, A. P., Silva, C. M., Muniz, M. B. D. S. R., & Viana, M. B. (2021) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2021.05.001 · Cited by 12
Self-citationReggiani, G., Coppadoro, B., Munaretto, V., Pieroni, A., Viaro, F., Manara, R., Beaubrun, A. C., Biffi, A., Baracchini, C., Sainati, L., et al. (2023) · European Journal Of Haematology · doi:10.1111/ejh.14022 · Cited by 14
“The association between high TCD velocities and elevated hemolysis markers has been previously described in different cohorts.(5,19,25,28,29) A similar trend was observed in the cohort of HbSS and HbSβ patients described here; however, the inverse correlation between TCDi results and Hb in the multivariate analysis wa…”
ResultRezende, P. V., Belisário, A. R., Oliveira, É. L., de Almeida, J. A., de Oliveira, L. M. M., Muniz, M. B. D. S. R., & Viana, M. B. (2019) · Haematologica · doi:10.3324/haematol.2018.209221 · Cited by 9
“As expected, the prevalence of β CAR and Benin haplotypes in SC children was very similar to that already reported for our SS children in Minas Gerais.(11) Many studies indicate a gradually less severe clinical outcome in patients with the Arab-Indian, Senegal, Benin, and CAR haplotypes,(3) probably related to the obs…”
ResultSelf-citationEarley, E. J., Kelly, S., Fang, F., Alencar, C. S., Rodrigues, D. D. O. W., Cruz, D. T. S., Flanagan, J. M., Ware, R. E., Zhang, X., Gordeuk, V. R., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.18637 · Cited by 8
Belisário, A. R., Sales, R. R., de Toledo, N. E., Velloso‐Rodrigues, C., Silva, C. M., & Viana, M. B. (2017) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2016.09.017 · Cited by 9
Self-citationAssociation of laboratory markers and cerebral blood flow among sickle cell anemia children
Adanho, C. S. A., Yahouédéhou, S. C. M. A., Santana, S. S., Vieira, C., Santiago, R. P., de Santana, J. M., Pitanga, T. N., Aleluia, M. M., Maffili, V. V., Leite, I. P. R., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.914466 · Cited by 8
“The increase in these inflammatory biomarkers, specifically in the TCD3 group when compared to the TCD1 group, besides to confirming the association of these biomarkers with stroke risk, suggests an association between recruitment of activated-inflammatory cells and acute stroke occurrence (43, 54).”
ResultSales, R. R., Nogueira, B. L., Belisário, A. R., Faria, G., Mendes, F. G., Viana, M. B., & Luizon, M. R. (2022) · Journal of Human Genetics · doi:10.1038/s10038-022-01079-0 · Cited by 9
“High reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort, as reported by our group of researchers [38].”
BackgroundSelf-citationGenetic Modifiers of Stroke in Patients with Sickle Cell Disease—A Scoping Review
Oni, M. O., Brito, M., Rotman, C., & Archer, N. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126317 · Cited by 5
Hassab, H. M. A., Hanafi, M., ElBeheiry, A. A., Hassan, M., & Chazli, Y. E. (2022) · The Indian Journal of Pediatrics · doi:10.1007/s12098-022-04181-5 · Cited by 2
Kumari, A., Chauhan, G., Chaudhuri, P. K., Kumari, S., & Prasad, A. (2024) · Hemoglobin · doi:10.1080/03630269.2024.2340685 · Cited by 1
“Using the Q-Genie tool, four studies were classified as having good quality [6, 8, 44, 45], twenty-six as moderate quality [13–15, 23–25, 27–29, 31, 32, 43, 46–59] and seven as poor quality [24, 26, 30, 33, 46–48].”
BackgroundMethodInfluentialMarques, T. R. D. O. C., Vidal, S. A., Costa, H. A. D., & Souza, A. I. (2026) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2026.106458 · Cited by 1
Andemariam, B., Kuo, K. H. M., Algahtani, F. H., Kindi, S. A., Ataga, K. I., Bartolucci, P., Campbell, A., Colombatti, R., Glaros, A. K., Hafraoui, K., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)01480-7 · Cited by 1
Ogbaselase, F. A., Williams-Kirkwood, W., Johal, S. K., Bailey, A., Jackson, E. A., Davis, D. B., & Karlson, C. (2024) · Clinical Pediatrics · doi:10.1177/00099228241306233 · Cited by 3
de Azevedo, J. T. C. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-14112019-123958 · Cited by 2
Adanho, C. S. A. (2018) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Oliveira, J. M., Arcanjo, G. D. S., Domingos, I. F., Batista, J. V. G. F., Pereira‐Martins, D. A., Batista, T. H. C., Hatzlhofer, B. L. D., Falcão, D. A., Diniz, M. V., Silva, A. P., et al. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107474
Metadata
- Authors
- Belisário, A. R., Sales, R. R., Toledo, N. E., Muniz, M. B. D. S. R., Velloso-Rodrigues, C., Silva, C. M., & Viana, M. B.
- Affiliations
- Universidade Federal de Minas Gerais (BR)
- Fundação Centro de Hematologia e Hemoterapia de Minas Gerais (BR)
- Corresponding author
- Belisário, André Rolim
- ORCID
- Venue
- Annals of Hematology
- Published
- 2016-08-13
- Volume
- 95
- Issue
- 11
- Pages
- 1869-1880
- ISSN
- 0939-5555 (ISSN-L)
- 1432-0584
- OpenAlex
- W2512353492
- Cited by
- 29
- References
- 63
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 7 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Hematology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (BR) (PPM-00266-13)
- Conselho Nacional de Desenvolvimento CientÃfico e Tecnológico (304530/2011-5)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- sickle cell disease, reticulocyte count, acute cerebral ischemia, stroke risk, children, single nucleotide polymorphisms, acute chest syndrome, white blood cell count, risk prediction
- MeSH terms
- Acute Disease, Anemia, Sickle Cell, Brain Ischemia, Child, Female, Follow-Up Studies, Haplotypes, Humans, Infant, Newborn, Leukocyte Count, Male, Proteoglycans, Risk, Risk Factors, Tumor Necrosis Factor-alpha, Incidence, Ultrasonography, Doppler, Transcranial, Reticulocyte Count, Receptors, Transforming Growth Factor beta, Polymorphism, Single Nucleotide, Receptor, TIE-2, beta-Globins, Acute Chest Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.